Ypsomed AG Revenue and Competitors

Blackheath, AU

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Ypsomed AG's estimated annual revenue is currently $420.2M per year.(i)
  • Ypsomed AG's estimated revenue per employee is $251,000

Employee Data

  • Ypsomed AG has 1674 Employees.(i)
  • Ypsomed AG grew their employee count by 8% last year.

Ypsomed AG's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Head Account & Business Development, VPReveal Email/Phone
3
VPReveal Email/Phone
4
Product Area Head Pens / VPReveal Email/Phone
5
Head Marketing & Sales ItalyReveal Email/Phone
6
Head Process ManagementReveal Email/Phone
7
Head LearningReveal Email/Phone
8
Head Regulatory AffairsReveal Email/Phone
9
Head Investor Relations, Group ControllerReveal Email/Phone
10
Head Indirect SalesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$17.1M68-4%N/AN/A
#2
$26.9M1078%N/AN/A
#3
$24.8M995%N/AN/A
#4
$19.1M760%N/AN/A
#5
$30.4M1214%N/AN/A
#6
$74.3M296N/AN/AN/A
#7
$40.2M1605%N/AN/A
#8
$74M29530%N/AN/A
#9
$420.2M16748%N/AN/A
#10
$51.5M2051%N/AN/A
Add Company

What Is Ypsomed AG?

The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years' experience. As a leader in innovation and technology, Ypsomed is the preferred partner for pharmaceutical and biotech companies for the supply of pens, autoinjectors and infusion systems to administer liquid drugs. Ypsomed promotes and sells its product portfolio under the umbrella brands mylife Diabetescare directly to patients or through pharmacies and clinics and under YDS Ypsomed Delivery Systems as business-to-business to pharmaceutical companies. Ypsomed has its headquarters in Burgdorf, Switzerland, and operates a global network of manufacturing sites, subsidiaries and distributors. The Ypsomed Group employs around 1300 employees. diabetes care, manufacturer, injection systems, selfcare solutions, blood glucose monitoring systems, infusion systems, insulin pumps

keywords:N/A

N/A

Total Funding

1674

Number of Employees

$420.2M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Ypsomed AG News

2022-04-17 - Other news to note for April 27, 2022

Chicago-based Abbott Laboratories; Camdiab Ltd., of Cambridge, U.K.; and Ypsomed AG, of Burgdorf, Switzerland, partnered to develop and...

2022-04-17 - Ypsomed : Abbott and CamDiab unveil new automated insulin ...

YPSOMED HOLDING AG. YPSN. Delayed Quote. Delayed - 04/26 11:31:01...

2022-04-17 - Catheters, Needles, And Cannulas Market Size, Outlook And ...

Ypsomed Holding AG, Revolutions Medical Corp, Medtronic PLC, Boston Scientific Corporation, HTL-STREFA, Unilife Corp, Terumo Medical...

2021-11-19 - Ypsomed : Satisfied employees

11/19/2021 - 9:53amYpsoStory Ypsomed receives Swiss Employer Award 2021 Ypsomed has received the Swiss Employer Award 2021 and was voted among the top seven. This award confirms our commitment to employee satisfaction, loyalty and identification with the company. On 18.11.2021, Ypsomed was ho ...

2021-11-04 - Ypsomed is growing and expects a further increase

11/04/2021 - 7:00amAd hoc announcement pursuant to Art. 53 LR Burgdorf - Ypsomed (SWX: YPSN) generated a growth in turnover of 11.6% in the first half of 2021/22 compared to the previous year and achieved a consolidated total turnover of CHF 222.6 million. On its continued growth trend, the com ...